PRODUCT DETAILS (US)
FiberNet® EP System Design
Clinical Experience
Currently for investigational use only, the FiberNet system has been evaluated in over 200 patients worldwide. Enrolling trials include the recently initiated EPIC Pivotal Trial in the U.S. and EPIC Europe for the carotid artery indication, and the RETREIVE feasibility study for the saphenous vein graft indication.
Notice of Availability
Caution
Investigational device, limited by Federal Law to Investigational Use.
Contact Us Today
For more information on the FiberNet system and participation in ongoing or future investigational trials, contact us today.